BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 24010301)

  • 1. Curcumol metabolized by rat liver S9 fraction and orally administered in mouse suppressed the proliferation of colon cancer in vitro and in vivo.
    Zhou Y; Moon JH; Kim JT; Qiu S; Lee SB; Park HJ; Son MJ; Lee GY; Kwon JW; Park SH; Auh JH; Lee HJ
    Food Sci Biotechnol; 2024 Jan; 33(1):171-180. PubMed ID: 38186621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead-Induced Cell Cycle Arrest in Human Liver Carcinoma (HepG
    Yedjou CG; Tchounwou PB
    Met Ions Biol Med; 2011; 11():242-246. PubMed ID: 26401103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway.
    Li S; Zhou G; Liu W; Ye J; Yuan F; Zhang Z
    Oncol Res; 2021 Sep; 28(7):685-700. PubMed ID: 32886059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.
    Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S
    Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line.
    Elnawasany S; Haggag YA; Shalaby SM; Soliman NA; El Saadany AA; Ibrahim MAA; Badria F
    BMC Complement Med Ther; 2023 Jul; 23(1):270. PubMed ID: 37516826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups.
    Li Z; Hao E; Cao R; Lin S; Zou L; Huang T; Du Z; Hou X; Deng J
    Chin Herb Med; 2022 Oct; 14(4):479-493. PubMed ID: 36405057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling.
    Gao J; Hou D; Hu P; Mao G
    Transl Cancer Res; 2021 May; 10(5):2437-2450. PubMed ID: 35116559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p/PI3K/AKT and ERK/NF-κB signaling pathways.
    Ning N; Liu S; Liu X; Tian Z; Jiang Y; Yu N; Tan B; Feng H; Feng X; Zou L
    J Cancer; 2020; 11(7):1679-1692. PubMed ID: 32194780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumol: From Plant Roots to Cancer Roots.
    Wei W; Rasul A; Sadiqa A; Sarfraz I; Hussain G; Nageen B; Liu X; Watanabe N; Selamoglu Z; Ali M; Li X; Li J
    Int J Biol Sci; 2019; 15(8):1600-1609. PubMed ID: 31360103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor Mechanisms of Curcumae Rhizoma Based on Network Pharmacology.
    Bi YH; Zhang LH; Chen SJ; Ling QZ
    Evid Based Complement Alternat Med; 2018; 2018():4509892. PubMed ID: 29636777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma.
    Hu B; An HM; Wang SS; Chen JJ; Xu L
    Molecules; 2016 Jan; 21(2):142. PubMed ID: 26828466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide from Phellinus linteus induces S-phase arrest in HepG2 cells by decreasing calreticulin expression and activating the P27kip1-cyclin A/D1/E-CDK2 pathway.
    Li YG; Ji DF; Zhong S; Liu PG; Lv ZQ; Zhu JX; Chen JE; Chen HP
    J Ethnopharmacol; 2013 Oct; 150(1):187-95. PubMed ID: 24001891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].
    Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism study on anti-proliferative effects of curcumol in human hepatocarcinoma HepG2 cells].
    Huang LZ; Wang J; Lu FT; Yang FC; Chen X; Hong X; Jiang XS
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1812-5. PubMed ID: 24010301
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.